[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

Can You Stop Myeloma Treatment and Still Stay in Remission?

Can You Stop Myeloma Treatment and Still Stay in Remission? image

Can You Stop Myeloma Treatment and Still Stay in Remission?

Webinar
event Jul 29, 2025 / 01:00PM - 02:00PM EDT
link icon facebook logo X logo linkedin logo reddit logo email icon
videocam
Can't make it to the event?
We send a recording to all registered participants of the event!

Event Description

Join us for an insightful webinar with Dr. Samer Al Hadidi as he discusses the evolving role of fixed duration treatment in multiple myeloma. For many years, treatment has continued indefinitely—until relapse or intolerable side effects. But emerging research is challenging that standard. Dr. Al Hadidi will share insights from his ongoing studies, exploring how deeper, more durable responses may allow some patients to safely pause treatment. Learn what this shift could mean for your care and the future of myeloma therapy.

Schedule & Agenda

The panelist Cynthia Cahoon, RN
1:00 PM
Introductions
Cynthia Cahoon, RN

Cynthia introduces the agenda of the event and featured speaker Samer Al Hadidi, M.D., M.S.(CRDSA), FACP

The panelist Samer Al Hadidi, M.D., M.S.(CRDSA), FACP
1:05 PM
Presentation
Samer Al Hadidi, M.D., M.S.(CRDSA), FACP

Dr. Hadidi talks about stopping myeloma treatment and remission

Event panelist Audience
1:35 PM
Questions and Answers
Audience

Type your questions in the chat and we will answer them! 

Speakers & Moderators

The panelist Cynthia Cahoon, RN
Cynthia Cahoon, RN

Cynthia is a newborn ICU nurse by trade that has spent the last six years in the medical device industry educating nurses and doctors about devices that are new to their facility. In her spare time she enjoys hiking, traveling the world with her family, and creating Halloween animatronics for her annual front yard display. She has a passion for life-long learning and enjoys sharing what she learns with the people around her.

Read Bio
The panelist Samer Al Hadidi, M.D., M.S.(CRDSA), FACP
Samer Al Hadidi, M.D., M.S.(CRDSA), FACP
Michigan

Samer Al Hadidi, M.D., M.S.(CRDSA), FACP, is an associate professor of Medicine. He earned his medical degree from University of Jordan, and his M.S.(CRDSA) at the School of Public Health and Biostatistics at the University of Michigan-Ann Arbor. Dr. Al Hadidi trained in Internal Medicine in Hurley Medical Center/Michigan State University and Hematology & Oncology in Baylor College of Medicine. Dr. Al Hadidi is a member of the American Society of Clinical Oncology (ASCO), the American Society of Hematology (ASH), the American Association for Cancer Research (AACR) and the American Society for Transplantation and Cellular Therapy  (ASTCT). Dr. Al Hadidi research interests include plasma cell dyscrasias including multiple myeloma with a focus on drug development, cellular therapy, immunotherapy, health equity and medical education.

Read Bio
HealthTree Connect Icon

Join the Conversation

This event is part of the Treatments & Drugs group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Blood Cancer Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.